Select Committee on Science and Technology Appendices to the Minutes of Evidence


APPENDIX 57

Memorandum submitted by Guy's and St Thomas' Hospital Trust

WITNESSES:

  Martine A Huit, RGN, BSc, Post Graduate Certificate in Clinical Teaching (Australia), Lymphoedema Nurse Specialist, Manual Lymph Drainage Therapist, 18 months experience in the field of lymphoedema management, 17 years in nursing.

  St Thomas' Hospital, Department of Palliative Care, First Floor, South Wing, Block 6a, Lambeth Palace Road, London SE1 7EH.

  Wendy Harlow, Research Project Co-ordinator in Oncology, Research and Development, 3rd Floor West Wing, Worthing Hospital, Lyndhurst Road, Worthing BN11 2DH.

  Jenny Veitch, RGN, Lymphoedema Nurse Specialist, Manual Lymph Drainage Therapist, nine years experience in the field of lymphoedema managment. 25 years in nursing.

  Guy's Hospital, Department of Palliative Medicine, Basement New Guy's House, St. Thomas' Street, London SE1 9RT.

INTRODUCTION

  Cancer and treatment for cancer are the main causes of lymphoedema[28] in the Western world. Lymphoedema represents the ". . . end-stage failure of lymph drainage . . ." (Mortimer, 1990:8), therefore, it is a condition that cannot be cured. It is regretful to acknowledge that "The physical and psychological impact of lymphoedema is often compounded by the failure of health care professionals to offer appropriate care." (Todd, 1998:230). In addition current research into effective methods of treating lymphoedema are not conclusive or consistent.

  Although the knowledge base surrounding the treatment of lymphoedema is expanding in the UK, evidence has demonstrated that a lack of knowledge amongst health care professionals is only one factor that affects patients' access to appropriate treatment for this condition. In addition, too many interventions in the management of lymphoedema are based on anecdotal evidence and further research is necessary in many different areas (outlined in this paper), if treatment methods are to be standardized, and if high standards in care are to be achieved.

  1.  It is estimated that in the UK, 25 to 38 per cent of women who undergo treatment for breast cancer will develop lymphoedema (Kissin et al 1986).

  2.  The incidence of lymphoedema following treatment of other cancers in the UK is not known, but patients are referred to lymphoedema clinics with facial, midline and leg oedema (swelling) following diagnosis/treatment for cancer.

  3.  The incidence of onset of lymphoedema, in the UK following invasive investigations of patients who were in the "at risk" category of developing this condition, secondary to treatment for cancer, is not known.

  4.  The Department of Health doe not have figures on the incidence of lymphoedema in the UK, nor does it possess guidelines on current best practice for the treatment of this condition.


  5.  Lack of knowledge amongst health care professionals is cited as one for the main causes of late referral and/or inappropriate treatment of lymphoedema (Todd, 1998). This has implications for patients and their family members, members of the multi-professional health care team and the long-term financial cost to the NHS and the community.

  6.  Members of "The British Lymphology Society (BLS) Research Forum"[29] meet on a quarterly basis. Wendy Harlow and John Sitzia, (researchers at Worthing Hospital), are currently working in conjunction with BLS to conduct a "National Survey of Priorities" amongst health care professionals working in lymphoedema management. The potential benefits that could be derived from conducting more extensive research in the field of lymphoedema management, (including a survey amongst patients), have been discussed. Lack of resources, including funding, continues to be the main barrier restricting developments in research. A dedicated team with experience in cancer research could use their expertise to gather and collate information and data from the 213 Lymphoedema Clinics that exist throughout the UK.

  7.  Conducting research is necessary if there is to be:

    (i)  Improvement in access to appropriate services for patients who have developed lymphoedema as a consequence/secondary to treatment for cancer.

    (ii)  Co-ordination of services with better use of available resources.

    (iii)  Reduction in the amount of money spent in the long-term on patients with lymphoedema if education amongst health care professionals is addressed. This is because early referral to appropriate services, where patients receive appropriate treatment and advice can reduce long-term complications, and therefore, cost in terms of physical and psychological distress to the patient and financial cost to the NHS. Early appropriate intervention may also increase the likelihood of patients being able to manage their condition at home, without the need for repeated periods of treatment in out-patient departments.

    (iv)  Improvement/standardisation in the treatment offered by lymphoedema therapists, basing practice on sound scientific evidence.

  8.  Current treatment/management programmes for patients with lymphoedema, that has developed secondary to cancer/cancer treatment, needs to be validated through appropriate scientific research. To date, insufficient data is available in numerous areas, including:

    (i)  Assessment and treatment of skin conditions, including acute inflammatory episodes.

    (ii)  Musculo-skeletal problems.

    (iii)  Range of movement and mobility.

    (iv)  The role of exercise in the treatment programme.

    (v)  Psychological and social issues for patients.

    (vi)  Incidence and prevalence of lymphoedema following treatment for cancer.

    (vii)  The role of manual lymphatic drainage.[30]

    (viii)  Level of knowledge amongst health care professionals about lymphoedema.

    (ix)  The selection and use of compression hosiery.[31]

    (x)  Recurrence of disease in patients with lymphoedema.

    (xi)  Exacerbation of lymphoedema following invasive investigations.

    (xii)  Onset of lymphoedema following invasive investigations on patients in the "at risk" category.

CONCLUSION

  Patients attending the lymphoedema clinic with a history of cancer frequently present with multiple, complex health problems. Access to appropriate services and appropriate treatment can help to control swelling, reduce the risk of associated complications developing, including psychological distress. Further research is required to support current theories, including the psychological impact this condition has on patients, if optimum standards in the treatment of patients and standardisation in practice are to be achieved. Funding cancer research in this area has the potential for far reaching consequences throughout the UK. In addition, it is envisaged findings would also be of interest internationally.

REFERENCES:

  Fentem PH (1990) Defining the compression provided by hosiery and bandages. CARE Science and Practice 8(3):53-55.

  Foldi E, Foldi M, Clodius L (1989) The lymphoedema chaos: A lancet. Annals of Plastic Surgery 22 (6):505-515.

  Kissin MW, Querci della Roveret G, Easton D and Wesbury G (1986) Risk of lymphoedema following the treatment of breast cancer. British Journal of Surgery 73:580-584.

  Mortimer P (1990) Investigation and management of lymphoedema. Vascular Medicine Review 1:1-20.

  Mortimer P (1995) Managing lymphoedema. Clinical and Experimental Dermatology 20:98-106.

  Mortimer P (1997) Strategy for Lymphoedema Care, British Lymphology Society.

  Todd JE (1998) Lymphoedema—a challenge for all healthcare professionals International Journal of Palliative Nursing 4(5):230-239.

12 June 2000


28   Lymphoedema is chronic swelling that develops in one or more anatomical regions of the body. Lymphoedema cannot be cured but can be controlled with appropriate treatment and patient compliance (Mortimer, 1990). Back

29   "The British Lymphology Society is a multi-disciplinary group of health care professionals and other interested parties directly involved in promoting the management of lymphoedema or interested in furthering the work of the society." Mortimer P (1997). Back

30   Manual lymphatic drainage is a specialised technique that stimulates lymph drainage through collateral pathways and removes protein from the interstitial spaces (Foldi, 1985). Back

31   Compression hosiery are garments that have a compression value. That is, they have an elasticity that makes it possible to fit them around a limb, allowing full range of movement with a graduated compression exerted when worn (Fentern, 1990). This external pressure helps to limit swelling and stimulates flow of lymph towards the root of the limb (Mortimer, 1995). Back


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2000
Prepared 28 July 2000